ASRS
BBIO icon

Arizona State Retirement System’s BridgeBio Pharma BBIO Stock Holding History

Arizona State Retirement System’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
40,501
+802
+2% +$56.2K 0.02% 637
2026
Q1 		$2.95M Sell
39,699
-479
-1% -$34.7K 0.02% 608
2025
Q4 		$3.07M Sell
40,178
-1,954
-5% -$128K 0.02% 600
2025
Q3 		$2.19M Buy
42,132
+3,302
+9% +$161K 0.01% 751
2025
Q2 		$1.68M Buy
38,830
+3,634
+10% +$132K 0.01% 844
2025
Q1 		$1.22M Sell
35,196
-274
-0.8% -$9.24K 0.01% 963
2024
Q4 		$973K Buy
35,470
+3,141
+10% +$81.2K 0.01% 1113
2024
Q3 		$823K Buy
32,329
+1,472
+5% +$38.6K 0.01% 1219
2024
Q2 		$782K Buy
30,857
+2,171
+8% +$59.4K 0.01% 1174
2024
Q1 		$887K Buy
28,686
+3,705
+15% +$126K 0.01% 1107
2023
Q4 		$1.01M Sell
24,981
-153
-0.6% -$4.59K 0.01% 1041
2023
Q3 		$663K Buy
25,134
+386
+2% +$11K 0.01% 1216
2023
Q2 		$426K Buy
24,748
+5,257
+27% +$79.1K ﹤0.01% 1511
2023
Q1 		$323K Buy
19,491
+667
+4% +$7.78K ﹤0.01% 1663
2022
Q4 		$143K Buy
18,824
+763
+4% +$7.3K ﹤0.01% 2026
2022
Q3 		$180K Buy
18,061
+60
+0.3% +$623 ﹤0.01% 1924
2022
Q2 		$163K Buy
18,001
+2,086
+13% +$17.4K ﹤0.01% 2001
2022
Q1 		$162K Sell
15,915
-2,224
-12% -$22.8K ﹤0.01% 2061
2021
Q4 		$303K Sell
18,139
-160
-0.9% -$6.77K ﹤0.01% 1829
2021
Q3 		$858K Buy
18,299
+78
+0.4% +$4.18K 0.01% 1191
2021
Q2 		$1.11M Buy
18,221
+3,027
+20% +$173K 0.01% 1033
2021
Q1 		$936K Buy
+15,194
New +$994K 0.01% 1165

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Arizona State Retirement System's BBIO Position: Q2 2026 in Review

Arizona State Retirement System increased its BridgeBio Pharma (BBIO) stake by 2% in Q2 2026, buying an estimated $56.2K and bringing the position to 40,501 shares worth $3.02M. The position accounts for 0.02% of the portfolio, ranked #637.

Arizona State Retirement System first reported a position in BBIO in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.07M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Arizona State Retirement System held 40,501 shares of BridgeBio Pharma worth $3.02M as of Q2 2026.
  • Arizona State Retirement System bought 802 BridgeBio Pharma shares in Q2 2026, an estimated $56.2K.
  • BridgeBio Pharma made up 0.02% of Arizona State Retirement System's portfolio in Q2 2026, its #637 holding.
  • Arizona State Retirement System first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 22 quarters since.
  • Arizona State Retirement System's BridgeBio Pharma position peaked at $3.07M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.